This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients <21 years of age; the effect of empagliflozin in patients with heart failure across the spectrum of LVEF; and the safety and immunogenicity profiles of different COVID-19 vaccine booster regimens.

Clinical Topics: Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, COVID-19 Hub, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Prevention, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Imaging, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement, Acute Heart Failure, Echocardiography/Ultrasound, Magnetic Resonance Imaging

Keywords: EaglesEyeView, Adenoviridae, Coronavirus, COVID-19, COVID-19 Vaccines, Fatigue, Headache, Immunity, Immunoglobulin G, Meningococcal Vaccines, Myocarditis, Nanoparticles, Primary Prevention, RNA, Messenger, SARS-CoV-2, T-Lymphocytes, Regulatory, Vaccination, Vaccines, Conjugate, Viral Vaccines, Adolescent, Arrhythmias, Cardiac, Chest Pain, COVID-19, COVID-19 Vaccines, Diagnostic Imaging, Echocardiography, Edema, Electrocardiography, Gadolinium, Length of Stay, Magnetic Resonance Imaging, Myocarditis, Pediatrics, RNA, Messenger, Secondary Prevention, Stroke Volume, Troponin, Vaccination, Ventricular Function, Left, Cardiomyopathies, Geriatrics, Glucosides, Heart Failure, Hospitalization, Outcome Assessment, Health Care, Risk Assessment, Secondary Prevention, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Ventricular Function, Left

< Back to Listings